CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Option exercise Director acquired 3,388 shares (option exercise)
- 4 Option exercise Director acquired 1,976 shares (option exercise)
- 4 Option exercise Director acquired 1,976 shares (option exercise)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Planned sale Chief Executive Officer sold 12,115 shares at $48.84 ($591,697)
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 1,362 shares at $44.39 ($60,459)
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Director sold 7,791 shares at $27.55 ($214,642)
- 4 Open-market sale Director sold 1,285 shares at $31.62 ($40,632)
- 4 Open-market sale Director sold 4,715 shares at an average $32.00 ($150,899)
- 4 Open-market sale Principal Accounting Officer sold 1,913 shares at $31.75 ($60,738)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 12 of 66 · 1,304 filings